![Harout Semerjian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harout Semerjian
Vorstandsvorsitzender bei GLYCOMIMETICS, INC.
Vermögen: 6 225 $ am 31.12.2024
Profil
Harout Semerjian is currently the President, Chief Executive Officer & Director at GlycoMimetics, Inc. He is also a Director at Biotechnology Innovation Organization.
Previously, he served as the President, Chief Executive Officer & Director at Immunomedics, Inc. in 2020.
From 2018 to 2020, he held the position of Chief Commercial Officer & Executive VP at Ipsen SA and Ipsen Pharma SAS.
Mr. Semerjian holds an MBA from Queen's University and Cornell University.
He also completed his undergraduate studies at Lebanese American University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
0,04% | 15.03.2024 | 25 000 ( 0,04% ) | 6 225 $ | 31.12.2024 |
Aktuelle Nachrichten zu Harout Semerjian
Aktive Positionen von Harout Semerjian
| Unternehmen | Position | Beginn |
|---|---|---|
| GLYCOMIMETICS, INC. | Vorstandsvorsitzender | 06.08.2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | 01.10.2023 |
Ehemalige bekannte Positionen von Harout Semerjian
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOMEDICS, INC. | Vorstandsvorsitzender | 27.05.2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | 30.04.2020 |
| IPSEN | Corporate Officer/Principal | 01.04.2020 |
Ausbildung von Harout Semerjian
| Cornell University | Masters Business Admin |
| Queen's University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IPSEN | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
